We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$76.9B
AUM Growth
+$11.3B
Cap. Flow
+$9.16B
Cap. Flow %
11.92%
Top 10 Hldgs %
31.81%
Holding
7,054
New
709
Increased
2,754
Reduced
2,613
Closed
569

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$376M
2
AAPL icon
Apple
AAPL
+$264M
3
STJ
St Jude Medical
STJ
+$263M
4
MSFT icon
Microsoft
MSFT
+$260M
5
BABA icon
Alibaba
BABA
+$172M

Sector Composition

Rank Sector Weight
1 Technology 5.56%
2 Healthcare 4.73%
3 Financials 4.3%
4 Consumer Discretionary 3.31%
5 Energy 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRDX
5151
DELISTED
Surmodics
SRDX
$21K ﹤0.01%
878
+705
+408% +$15.4K
VNDA icon
5152
PUT
Vanda Pharmaceuticals
VNDA
$307M
$21K ﹤0.01%
1,900
MRTX
5153
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$21K ﹤0.01%
3,895
+3,131
+410% +$49.9K
VIVO
5154
CALL
DELISTED
Meridian Bioscience Inc
VIVO
$21K ﹤0.01%
1,100
-2,600
-70% -$51K
MTOR
5155
PUT
DELISTED
MERITOR, Inc.
MTOR
$21K ﹤0.01%
2,900
+1,000
+53% +$8.24K
ENIA
5156
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$21K ﹤0.01%
2,455
-44,594
-95% -$355K
WCG
5157
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
$21K ﹤0.01%
200
-21,900
-99% -$2.14M
GST
5158
DELISTED
Gastar Exploration Inc.
GST
$21K ﹤0.01%
+19,172
New +$22.6K
CPLA
5159
PUT
DELISTED
Capella Education Company
CPLA
$21K ﹤0.01%
400
+300
+300% +$15.6K
CASC
5160
DELISTED
Cascadian Therapeutics, Inc.
CASC
$21K ﹤0.01%
3,727
+2,120
+132% +$14.4K
DTSI
5161
DELISTED
DTS, Inc.
DTSI
$21K ﹤0.01%
816
-1,665
-67% -$39.5K
UFS
5162
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
$21K ﹤0.01%
600
-100
-14% -$3.85K
RBS.PRL.CL
5163
DELISTED
Royal Bank Of Scotland Group Plc
RBS.PRL.CL
$21K ﹤0.01%
850
ASMB icon
5164
Assembly Biosciences
ASMB
$498M
$20K ﹤0.01%
+298
New +$19.6K
BRKR icon
5165
Bruker
BRKR
$9.57B
$20K ﹤0.01%
889
-10,281
-92% -$275K
CPRT icon
5166
PUT
Copart
CPRT
$27B
$20K ﹤0.01%
3,200
-4,800
-60% -$27K
IDT icon
5167
IDT Corp
IDT
$1.64B
$20K ﹤0.01%
+1,660
New +$18.4K
OCUL icon
5168
Ocular Therapeutix
OCUL
$1.79B
$20K ﹤0.01%
3,905
+1,877
+93% +$18.6K
OIS icon
5169
CALL
Oil States International
OIS
$489M
$20K ﹤0.01%
600
PERI icon
5170
Perion Network
PERI
$375M
$20K ﹤0.01%
+5,592
New +$24.2K
PRAA icon
5171
PRA Group
PRAA
$663M
$20K ﹤0.01%
829
-669
-45% -$18.7K
RYAM icon
5172
Rayonier Advanced Materials
RYAM
$604M
$20K ﹤0.01%
1,489
+1,426
+2,263% +$17.5K
WPRT
5173
PUT
Westport Fuel Systems
WPRT
$33.4M
$20K ﹤0.01%
1,190
INFI
5174
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$20K ﹤0.01%
14,984
+14,682
+4,862% +$68.7K
XENT
5175
DELISTED
Intersect ENT, Inc
XENT
$20K ﹤0.01%
1,523
-1,248
-45% -$19.5K

Similar funds

Barclays's Q2 2016 Portfolio in Review

As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.

  • Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
  • Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
  • Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
  • Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
  • Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
  • Barclays opened 709 new positions and closed 569 in Q2 2016.
  • Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.